The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
How cell death shapes cancer
Open accessAbstract
Apoptosis has been established as a mechanism of anti-cancer defense. Members of the BCL-2 family are critical mediators of apoptotic cell death in health and disease, often found to be deregulated in cancer and believed to lead to the survival of malignant clones. However, over the years, a number of studies pointed out that a model in which cell death resistance unambiguously acts as a barrier against malignant disease might be too simple. This is based on paradoxical observations made in tumor patients as well as mouse models indicating that apoptosis can indeed drive tumor formation, at least under certain circumstances. One possible explanation for this phenomenon is that apoptosis can promote proliferation critically needed to compensate for cell loss, for example, upon therapy, and to restore tissue homeostasis. However, this, at the same time, can promote tumor development by allowing expansion of selected clones. Usually, tissue resident stem/progenitor cells are a major source for repopulation, some of them potentially carrying (age-, injury- or therapy-induced) genetic aberrations deleterious for the host. Thereby, apoptosis might drive genomic instability by facilitating the emergence of pathologic clones during phases of proliferation and subsequent replication stress-associated DNA damage. Tumorigenesis initiated by repeated cell attrition and repopulation, as confirmed in different genetic models, has parallels in human cancers, exemplified in therapy-induced secondary malignancies and myelodysplastic syndromes in patients with congenital bone marrow failure syndromes. Here, we aim to review evidence in support of the oncogenic role of stress-induced apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
Tsujimoto, Y., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,786
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,179
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,158
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Cleary, M. L., & Sklar, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7439 · Cited by 924
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892
Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K. H., Han, J., Chittenden, T., Ihle, J. N., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00244-7 · Cited by 879
Senescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798
Cooperative interaction between c-myc and bcl-2 proto-oncogenes
Fanidi, A., Harrington, E. A., & Evan, G. I. (1992) · Nature · doi:10.1038/359554a0 · Cited by 759
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2663 · Cited by 758
Caspase-independent cell death
Kroemer, G., & Martin, S. J. (2005) · Nature Medicine · doi:10.1038/nm1263 · Cited by 716
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
Ryoo, H. D., Gorenc, T., & Steller, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.019 · Cited by 624
Del Gaizo Moore, V., Brown, J. R., Certo, M., Love, T. M., Novina, C. D., & Letai, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28281 · Cited by 608
dMyc Transforms Cells into Super-Competitors
Moreno, E., & Basler, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00262-4 · Cited by 595
Bim is a suppressor of Myc-induced mouse B cell leukemia
Egle, A., Harris, A. W., Bouillet, P., & Cory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401471101 · Cited by 488
Luciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G., & Auberger, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206792 · Cited by 477
Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., di Fronzo, G., Rilke, F. O., & Veronesi, U. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.499 · Cited by 454
Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
Harris, C. C. (1991) · PubMed · Cited by 434
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress
Amundson, S. A., Myers, T. G., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202576 · Cited by 424
Apoptotic Cells Provide an Unexpected Source of Wnt3 Signaling to Drive Hydra Head Regeneration
Chera, S., Ghila, L., Dobretz, K., Wenger, Y., Bauer, C., Buzgariu, W., Martinou, J.-C., & Galliot, B. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.014 · Cited by 418
Drug resistance in cancer: Principles of emergence and prevention
Komarova, N. L., & Wodarz, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501870102 · Cited by 414
Bcl-2 protein expression and long-term survival in breast cancer.
Joensuu, H., Pylkkänen, L. H., & Toikkanen, S. (1994) · PubMed · Cited by 396
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
Kemp, C. J., Wheldon, T., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 368
Parker, J. E., Mufti, G. J., Rasool, F., Mijovic, A., Devereux, S., & Pagliuca, A. (2000) · Blood · doi:10.1182/blood.v96.12.3932 · Cited by 363
Huh, J. R., Guo, M., & Hay, B. A. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.015 · Cited by 355
p53-Mediated Hematopoietic Stem and Progenitor Cell Competition
Bondar, T., & Medzhitov, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.002 · Cited by 342
Myelodysplastic syndromes: the complexity of stem-cell diseases
Corey, S. J., Minden, M. D., Barber, D. L., Kantarjian, H., Wang, J. C. Y., & Schimmer, A. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2047 · Cited by 342
Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., Pla, M., Vasquez, N., Zhang, Q.-S., Pondarre, C., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.013 · Cited by 340
Pérez-Garijo, A., Martín, F. A., & Morata, G. (2004) · Development · doi:10.1242/dev.01432 · Cited by 339
Kuroda, J., Puthalakath, H., Cragg, M. S., Kelly, P. N., Bouillet, P., Huang, D. C. S., Kimura, S., Ottmann, O. G., Druker, B. J., Villunger, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606176103 · Cited by 336
Apoptosis, Stem Cells, and Tissue Regeneration
Bergmann, A., & Steller, H. (2010) · Science Signaling · doi:10.1126/scisignal.3145re8 · Cited by 328
Alter, B. P., Giri, N., Savage, S. A., Peters, J. A., Loud, J. T., Leathwood, L., Carr, A. G., Greene, M. H., & Rosenberg, P. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08212.x · Cited by 324
Vogler, M., Butterworth, M., Majid, A., Walewska, R. J., Sun, X.-M., Dyer, M. J. S., & Cohen, G. M. (2009) · Blood · doi:10.1182/blood-2008-08-173310 · Cited by 323
Dawson, S.-J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605736 · Cited by 317
Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!
Fan, Y., & Bergmann, A. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.001 · Cited by 309
Multiple cell death pathways as regulators of tumour initiation and progression
Jäättelä, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207513 · Cited by 283
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma
Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., Saito, H., & Hotta, T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370804 · Cited by 274
Erlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., & Villunger, A. (2005) · Blood · doi:10.1182/blood-2005-04-1595 · Cited by 264
Self-citationApoptosis and oncogenesis: give and take in the BCL-2 family
Llambi, F., & Green, D. R. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.001 · Cited by 262
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
Ringshausen, I., O'Shea, C. C., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.010 · Cited by 256
Engulfment Is Required for Cell Competition
Li, W., & Baker, N. E. (2007) · Cell · doi:10.1016/j.cell.2007.03.054 · Cited by 239
Fan, Y., & Bergmann, A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.003 · Cited by 238
Cell competition is a tumour suppressor mechanism in the thymus
Martins, V. C., Busch, K., Juraeva, D., Blum, C., Ludwig, C., Rasche, V., Lasitschka, F., Mastitsky, S. E., Brors, B., Hielscher, T., et al. (2014) · Nature · doi:10.1038/nature13317 · Cited by 231
Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Alter, B. P. (2007) · Hematology · doi:10.1182/asheducation-2007.1.29 · Cited by 230
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice
Qiu, W., Wu, B., Wang, X., Buchanan, M. E., Regueiro, M. D., Hartman, D. J., Schoen, R. E., Yu, J., & Zhang, L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42917 · Cited by 193
Dahan, P., Martinez Gala, J., Delmas, C., Monferran, S., Malric, L., Zentkowski, D., Lubrano, V, Toulas, C., Cohen-Jonathan Moyal, E., & Lemarie, A. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.509 · Cited by 187
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Cragg, M. S., Harris, C., Strasser, A., & Scott, C. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2615 · Cited by 185
Paradoxical Dependencies of Tumor Dormancy and Progression on Basic Cell Kinetics
Enderling, H., Anderson, A. R. A., Chaplain, M. A. J., Beheshti, A., Hlatky, L., & Hahnfeldt, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2115 · Cited by 181
Waisfisz, Q., Morgan, N. V., Savino, M., de Winter, J. P., van Berkel, C. G. M., Hoatlin, M. E., Ianzano, L., Gibson, R. A., Arwert, F., Savoia, A., et al. (1999) · Nature Genetics · doi:10.1038/11956 · Cited by 173
Kaspers, G. J. L., Pieters, R., Van Zantwijk, C. H., VanWering, E. R., Van Der Does-Van Den Berg, A., & Veerman, A. J. P. (1998) · Blood · doi:10.1182/blood.v92.1.259.413k21_259_266 · Cited by 168
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
Labi, V, Erlacher, M., Kiessling, S., & Villunger, A. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401940 · Cited by 167
Self-citationTargeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
Kelly, G. L., Grabow, S., Glaser, S. P., Fitzsimmons, L., Aubrey, B. J., Okamoto, T., Valente, L. J., Robati, M., Tai, L., Fairlie, W. D., et al. (2014) · Genes & Development · doi:10.1101/gad.232009.113 · Cited by 166
Labi, V, Grespi, F., Baumgartner, F., & Villunger, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.37 · Cited by 165
Self-citationVick, B., Weber, A., Urbanik, T., Maass, T., Teufel, A., Krammer, P. H., Opferman, J. T., Schuchmann, M., Galle, P. R., & Schulze‐Bergkamen, H. (2008) · Hepatology · doi:10.1002/hep.22664 · Cited by 165
Soulier, J. (2011) · Hematology · doi:10.1182/asheducation-2011.1.492 · Cited by 161
Jäger, R., Herzer, U., Schenkel, J., & Weiher, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201353 · Cited by 159
Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis
Garrison, S. P., Jeffers, J. R., Yang, C., Nilsson, J. A., Hall, M. A., Rehg, J. E., Yue, W., Yu, J., Zhang, L., Onciu, M. M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00907-07 · Cited by 153
Irradiation selects for p53-deficient hematopoietic progenitors.
Marusyk, A., Porter, C. C., Zaberezhnyy, V., & DeGregori, J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000324 · Cited by 151
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
Michalak, E. M., Jansen, E. S., Happo, L., Cragg, M. S., Tai, L., Smyth, G. K., Strasser, A., Adams, J. M., & Scott, C. L. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.195 · Cited by 147
t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma
Roulland, S., Kelly, R. S., Morgado, E., Sungalee, S., Solal‐Céligny, P., Colombat, P., Jouve, N., Palli, D., Pala, V. M., Tumino, R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.8190 · Cited by 144
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia
Ploner, C., Rainer, J., Niederegger, H., Eduardoff, M., Villunger, A., Geley, S., & Kofler, R. (2007) · Leukemia · doi:10.1038/sj.leu.2405039 · Cited by 142
Wong, J. R., Morton, L. M., Tucker, M. A., Abramson, D. H., Seddon, J. M., Sampson, J. N., & Kleinerman, R. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.7844 · Cited by 136
Tehranchi, R., Fadeel, B., Forsblom, A., Christensson, B., Samuelsson, J., Zhivotovsky, B., & Hellström‐Lindberg, E. (2003) · Blood · doi:10.1182/blood-2002-06-1774 · Cited by 133
bcl-2 and apoptosis in lymph node positive breast carcinoma
Berardo, M. D., Elledge, R. M., de Moor, C., Clark, G. M., Osborne, C. K., & Allred, D. C. (1998) · Cancer · Cited by 130
Öfner, D., Riehemann, K., Maier, H., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.446 · Cited by 129
Michalak, E. M., Vandenberg, C. J., Delbridge, A. R. D., Wu, L., Scott, C. L., Adams, J. M., & Strasser, A. (2010) · Genes & Development · doi:10.1101/gad.1940110 · Cited by 129
Compensatory proliferation and apoptosis-induced proliferation: a need for clarification
Mollereau, B., Pérez-Garijo, A., Bergmann, A., Miura, M., Gerlitz, O., Ryoo, H. D., Steller, H., & Morata, G. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.82 · Cited by 124
Weber, A., Boger, R. J., Vick, B., Urbanik, T., Haybaeck, J., Zoller, S., Teufel, A., Krammer, P. H., Opferman, J. T., Galle, P. R., et al. (2009) · Hepatology · doi:10.1002/hep.23479 · Cited by 124
Mazumder, S., Choudhary, G. S., Al-harbi, S., & Almasan, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4106 · Cited by 121
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
Beverly, L. J., & VARMUS, H. E. (2009) · Oncogene · doi:10.1038/onc.2008.466 · Cited by 113
Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formationPreprint
Labi, V., Erlacher, M., Krumschnabel, G., Manzl, C., Tzankov, A., Pinon, J., Egle, A., & Villunger, A. (2010) · Genes & Development · doi:10.1101/gad.1940210 · Cited by 108
Self-citationHwang, J. S., Kobayashi, C., Agata, K., Ikeo, K., & Gojobori, T. (2004) · Gene · doi:10.1016/j.gene.2004.02.034 · Cited by 107
Death squads enlisted by the tumour suppressor p53
Michalak, E., Villunger, A., Erlacher, M., & Strasser, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.183 · Cited by 94
Self-citationHogarth, L., & Hall, A. G. (1999) · Blood · doi:10.1182/blood.v93.8.2671 · Cited by 91
Lai, H., Sun, C., Yu, M., Chen, H., Liu, H.-S., & Chu, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2 · Cited by 89
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation
Mackus, W. J. M., Kater, A. P., Grummels, A., Evers, L. M., Hooijbrink, B., Kramer, M. H. H., Castro, J. E., Kipps, T. J., van Lier, R. A. W., van Oers, M. H. J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403623 · Cited by 87
Cancer Survivorship: A Pediatric Perspective
Landier, W., & Bhatia, R. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0104 · Cited by 86
Anagnostou, V., Lowery, F. J., Zolota, V., Tzelepi, V., Gopinath, A., Liceaga, C., Παναγόπουλος, Ν., Frangia, K. B., Tanoue, L. T., Boffa, D. J., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-186 · Cited by 74
Ceccaldi, R., Briot, D., Larghero, J., Vasquez, N., d’Enghien, C. D., Chamousset, D., Noguera, M., Waisfisz, Q., Hermine, O., Pondarré, C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43836 · Cited by 72
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad
Frenzel, A., Labi, V., Chmelewskij, W., Ploner, C., Geley, S., Fiegl, H., Tzankov, A., & Villunger, A. (2009) · Blood · doi:10.1182/blood-2009-03-212670 · Cited by 68
Self-citationA generalized Luria–Delbrück model
Dewanji, A., Luebeck, E. G., & Moolgavkar, S. H. (2005) · Mathematical Biosciences · doi:10.1016/j.mbs.2005.07.003 · Cited by 64
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
Boehrer, S., Adès, L., Tajeddine, N., Hofmann, W.-K., Kriener, S., Bug, G., Ottmann, O. G., Ruthardt, M., Galluzzi, L., Fouassier, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.69 · Cited by 63
Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer
Kaklamanis, L., Savage, A. P., Whitehouse, R. M., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.310 · Cited by 63
Side, L. E., Curtiss, N. P., Teel, K., Kratz, C. P., Wang, P. W., Larson, R. A., Beau, M. M. L., & Shannon, K. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10320 · Cited by 62
Cancer stem cells in solid tumors: Is ‘evading apoptosis’ a hallmark of cancer?
Enderling, H., & Hahnfeldt, P. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2011.03.007 · Cited by 60
Super competition as a possible mechanism to pioneer precancerous fields
Rhiner, C., & Moreno, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp003 · Cited by 60
Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?
Sigurdson, A. J., & Jones, I. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206989 · Cited by 58
Hamilton, E., Pearce, L., Morgan, L. D., Robinson, S., Ware, V., Brennan, P., Thomas, N. S. B., Yallop, D., Devereux, S., Fegan, C., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09191.x · Cited by 57
Clinical significance of bcl-2 gene expression in human breast cancer tissues
Kobayashi, S., Iwase, H., Ito, Y., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005760013810 · Cited by 53
Binder, C. R., Marx, D., Overhoff, R., Binder, L., Schauer, A., & Hiddemann, W. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059064 · Cited by 52
Calandra, G. C., Bridger, G. J., & Fricker, S. P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_26 · Cited by 49
Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer
Wu, D., Huang, C.-C., Chang, S.-W., Chen, T. H., & Lee, H. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.170 · Cited by 49
Slape, C. I., Saw, J., Jowett, J. B. M., Aplan, P. D., Strasser, A., Jane, S. M., & Curtis, D. J. (2012) · Blood · doi:10.1182/blood-2012-05-430736 · Cited by 46
Watson, N. F., Madjd, Z., Scrimegour, D., Spendlove, I., Ellis, I. O., Scholefield, J. H., & Durrant, L. G. (2005) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-3-47 · Cited by 45
Morales, A. A., Olsson, A., Celsing, F., Österborg, A., Jondal, M., & Osorio, L. M. (2003) · Leukemia · doi:10.1038/sj.leu.2403183 · Cited by 42
Can loss of apoptosis protect against cancer?
Wodarz, D., & Komarova, N. L. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.03.005 · Cited by 41
Bcl-2 Is a Useful Prognostic Marker in Dukes' B Colon Cancer
Meterissian, S. H., Kontogiannea, M., Al-Sowaidi, M., Linjawi, A., Halwani, F., Jamison, B. M., & Edwardes, M. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0533-3 · Cited by 40
Luke, J. J., van de Wetering, C. I., & Knudson, C. M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401233 · Cited by 35
bcl-2 Expression and Apoptosis in Primary and Metastatic Breast Carcinomas
Villar, E., Redondo, M., Rodrigo, I., a, J. G. I., Avila, E., & Matilla, A. (2001) · Tumor Biology · doi:10.1159/000050608 · Cited by 35
BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer
Renouf, D. J., Wood-Baker, R. R., Ionescu, D. N., Leung, S. C. Y., Masoudi, H., Gilks, C. B., & Laskin, J. J. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318199e03a · Cited by 34
SHIBATA, Y., Hidaka, S., Tagawa, Y., & Nagayasu, T. (2004) · PubMed · Cited by 29
Vargas-Roig, L. M., Cuello-Carrión, F. D., Fernández-Escobar, N., Daguerre, P., Leuzzi, M., Ibarra, J., Gago, F. E., Nadin, S. B., & Ciocca, D. R. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.01.004 · Cited by 25
Zhao, X., He, Y., Gao, J., Zhao, C., Zhang, L., Tian, J., & Chen, H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8861 · Cited by 15
Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?
Pillai, K., Pourgholami, M. H., Chua, T. C., & Morris, D. L. (2013) · Europe PMC (PubMed Central) · Cited by 12
Moreno, E. (2014) · Nature · doi:10.1038/nature13337 · Cited by 11
Morata, G., & Ballesteros-Arias, L. (2014) · Science · doi:10.1126/science.aaa2345 · Cited by 10
Jäger, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.05.006 · Cited by 8
Cited by
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597
MOMP, cell suicide as a BCL-2 family business
Kalkavan, H., & Green, D. R. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.179 · Cited by 664
The Apoptosis Paradox in Cancer
Morana, O., Wood, W., & Gregory, C. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031328 · Cited by 420
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 401
Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living
Heitzer, E., Auinger, L., & Speicher, M. R. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.012 · Cited by 284
Metadata
- Authors
- Labi, V, & Erlacher, M.
- Venue
- Cell Death & Disease
- Published
- 2015-03-05
- Volume
- 6
- Issue
- 3
- Pages
- e1675-e1675
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2081613128
- Cited by
- 295
- References
- 131
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.